C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Citing Need to Assess Potential Risks. Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Women and Girls, Advisory Committee on Immunization Practices, AstraZeneca PLC, Centers for Disease Control and Prevention, Johnson & Johnson, Food and Drug Administration, your-feed-healthcare